
浏览全部资源
扫码关注微信
纸质出版日期:2012
移动端阅览
王岚, 杜茂波, 刘淑芝, 等. 冠心巴布膏活血化瘀作用研究[J]. 中国实验方剂学杂志, 2012,18(14):217-220.
WANG Lan, DU Mao-bo, LIU Shu-zhi, et al. Study of Promoting Blood Circulation for Removing Blood Stasis by Guanxin Cataplasm[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(14): 217-220.
目的: 探讨冠心巴布膏(冠心膏)的活血化瘀作用
为其临床应用提供实验依据 。方法: 采用大鼠sc肾上腺素加冰浴的血瘀证模型
观察冠心膏高、中、低3个剂量(含生药 10.0
5.0
2.5 g·kg-1)外用涂抹给药5 d对模型动物全血黏度、血浆黏度、纤维蛋白原含量、红细胞压积、血小板聚集的影响。采用iv脑垂体后叶素(0.5 U·kg-1)造成大鼠急性心肌缺血模型
观察冠心膏 (剂量同前) 外用涂抹给药7 d对模型动物心律失常的发生时间、持续时间及室性心律失常发生率的影响。结果: 冠心膏高剂量能降低血浆黏度[由(1.101±0.064) mPa·s降至(1.039±0.025) mPa·s]、血小板聚集率[由(54.92±6.53)% 降至(49.05±4.15)%]、200 s-1切变率下的全血黏度[由(3.81±0.31) mPa·s降至(3.53±0.27) mPa·s]
延迟心律失常的开始时间[由(20.90±7.74)s升至(36.08±16.91)s]
并降低心律失常的发生率(由75% 降至37.5%)及持续时间[由(1 133.75±298.71)s降至(881.20±115.48)s]。低剂量能降低10 s-1切变率下的全血黏度[由(7.14±0.88) mPa·s降至(6.38±0.69) mPa·s]以及200 s-1切变率下的全血黏度[由(3.81±0.31) mPa·s降至(3.48±0.15) mPa·s]
中剂量可以降低心律失常发生率(由75% 降至37.5%)和持续时间 [由(1 133.75±298.71)s降至(816.43±243.46)s]
与模型组比较均具有显著性差异(P<0.05
P<0.01)。结论: 冠心巴布膏可以改善血瘀证大鼠的血液流变学指标
防止心律失常的发生
具有一定的活血化瘀作用。
Objective: To investigate the actions of promoting blood circulation for removing blood stasis by Guanxin Cataplasm and provide the experimental basis for clinical applications of the cataplasm. Method: The rat blood stasis syndrome model was induced by subcutaneous injection of adrenalin with ice-bath
the indexes of hemorheology including fibrinogen
whole blood viscosity
plasma viscosity
packed cell volume and platelet aggregation.The acute rat myocardial ischemia model was established by sublingual vein injection of 0.5 U·kg-1 posterior pituitary
and the electrocardiogram ECGs were recorded by polygraph to determine the incidence of ventricular tachycardia(VT) and ventricular fibrillation(VF)
the mean duration and onset time of VT plus VF. Result: Compared with model group
high dosage group of guanxin cataplasm decreased plasma viscosity from (1.101±0.064) mPa·s to (1.039±0.025) mPa·s
platelet aggregation from (54.92±6.53)% to (49.05±4.15)%
and whole blood viscosity under the shear rate of 200 s-1from (3.81±0.31) mPa·s to (3.53±0.27) mPa·s; meanwhile the delayed duration of VT plus VF from (1 133.75±298.71 )s to (881.20±115.48)s and onset time of VT plus VF from (20.90±7.74)s up to (36.08±16.91)s with reduced incidence of VT plus VF from 75% to 37.5% were observed. Small and middle dosage group led to a reduction in whole blood viscosity under 10 s-1 from (7.14±0.88) mPa·s to (6.38±0.69) mPa·s and that under 200 s-1 from (3.81±0.31) mPa·s to (3.48±0.15) mPa·s shear rate
and in the incidence decreased from 75% to 37.5% and duration decreased from(1 133.75±298.71) s to (816.43±243.46) s for VT plus VF respectively(P<0.05
P<0.01). Conclusion: Guanxin cataplasm can obviously improve indexes of hemorheology and afford a protection against occurring of VT plus VF
which may contribute to its function of promoting blood circulation for removing blood stasis.
0
浏览量
2
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621